Citation Impact
Citing Papers
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Understanding and Mitigating Uncertainty in Online Exchange Relationships: A Principal–Agent Perspective1
2007 Standout
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy
2018
Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
2013 StandoutNobel
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Haemostatic materials for wound healing applications
2021 Standout
Evidence-Based Management of Anticoagulant Therapy
2012
Tissue plasminogen activator to prevent central venous access device infections: a systematic review of central venous access catheter thrombosis, infection and thromboprophylaxis
2007
Endocan: A novel inflammatory indicator in cardiovascular disease?
2015 Standout
Perioperative Management of Antithrombotic Therapy
2012 Standout
Oral Anticoagulant Therapy
2012 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding
2017
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Executive Summary
2012 Standout
Immunology and functional genomics of Beh�et's disease
2003
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Kidney Function Influences Warfarin Responsiveness and Hemorrhagic Complications
2009
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Massive transfusion and nonsurgical hemostatic agents
2008
Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data
2008
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Comprehensive Canadian Review of the Off-Label Use of Recombinant Activated Factor VII in Cardiac Surgery
2008
Guidelines for the Primary Prevention of Stroke
2014 Standout
[Treatment of cancer and thrombosis: practical approach].
2013
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2010 Standout
Article Commentary: Penny-Wise, Pound-Foolish? Highmark Medicare Services’ Proposal for Anticoagulation Clinic Reimbursement
2010
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Coagulopathy induced by acidosis, hypothermia and hypocalcaemia in severe bleeding.
2015
Projecting future drug expenditures—2005
2005
Hematological findings and complications of COVID ‐19
2020 Standout
Guidelines for the management of hemophilia
2012 Standout
Works of Mudi Misgav being referenced
Fatal pulmonary artery thrombosis in a patient with Behçetʼs disease, activated protein C resistance and hyperhomocystinemia
2000
The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillation
2006
Enoxaparin can be Used Safely in Patients with Severe Thrombocytopenia due to Intensive Chemotherapy Regimens
2004
Recombinant activated factor VII (NovoSeven™): addition to replacement therapy in acute, uncontrolled and life‐threatening bleeding
2004